Innovatus Capital Partners is a Investment Adviser And Portfolio Management Firm.
Innovatus Capital Partners, they focus on both real and financial assets. Their firm's investment in strategies that identifies distressed, disruptive, and growth opportunities.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 7, 2022
Eiger BioPharmaceuticals
|
Post-IPO Debt | $75M | Biotechnology | Yes |
|
Jun 7, 2022
Eiger BioPharmaceuticals
|
Post-IPO Equity | $5M | Biotechnology | Yes |
|
Mar 8, 2022
DNAnexus
|
Series H | $200M | Bioinformatics | — |
|
Feb 6, 2019
DNAnexus
|
Series F | $68M | Bioinformatics | — |